Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Gastric Cancer

  • Chun, Huan (Department of Surgery, Hanyang University College of Medicine) ;
  • Kwon, Sung-Joon (Department of Surgery, Hanyang University College of Medicine)
  • Received : 2010.10.15
  • Accepted : 2010.11.29
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: ${\alpha}$-fetoprotein (AFP)-producing gastric cancer is a rare tumor with high rates of liver metastasis and a poor prognosis. Many studies have been performed but there have been no comprehensive investigations of the clinicopathological and prognosis. Materials and Methods: Six hundred ninety four patients with gastric cancer who underwent a curative gastric resection in Hanyang University Hospital from February 2001 to December 2008 were evaluated retrospectively after excluding active or chronic hepatits, liver cirrhosis and preoperative distant metastasis. Among them, thirty five patients had an elevated serum level of AFP (>7 ng/ml) preoperatively. The clinicopathological features of AFP-producing gastric cancer were analyzed. Results: There was poorer differentiation, a higher incidence of lymph node metastasis, more marked lymphatic and vascular invasion in the AFP-positive group than in the AFP-negative group. The 5-year survival rate of the AFP-positive group was significantly poorer than that in the AFP-negative group (66% vs. 80%, P=0.002). A significantly higher incidence of liver metastasis was observed in the AFP-positive group than in the AFP-negative group (14.3% vs. 3.6%, P=0.002) with a shorter median time period from the operation to the metachronous liver metastasis (3.7 months vs. 14.1 months, P=0.043). Multivariate survival analysis revealed the depth of invasion, degree of lymph node metastasis and AFP-positivity to be the independent prognostic factors. Conclusions: AFP-producing gastric cancers have an aggressive behavior with a high metastatic potential to the liver. In addition, their clinicopathological features are quite different from the more common AFP-negative gastric cancer.

Keywords

References

  1. Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956;8:174. https://doi.org/10.3109/00365515609049266
  2. Nishimura H, Okamoto Y, Takahashi M, Fujita T. Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer. Gastroenterology 1976;71:497-499.
  3. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med 1970;78:1277-1278.
  4. Chang YC, Nagasue N, Abe S, Kohno H, Yamanoi A, Uchida M, et al. The characters of AFP-producing early gastric cancer. Nippon Geka Gakkai Zasshi 1990;91:1574-1580.
  5. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K. Alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn 1993;43:654-661.
  6. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992;87:321-325.
  7. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis and angiogenesis. Am J Gastroenterol 1999;94:1658-1663.
  8. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 2000;59:145-151. https://doi.org/10.1159/000012152
  9. Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss, 2002.
  10. Gitlin D, Boesman M. Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus. J Clin Invest 1966;45:1826-1838. https://doi.org/10.1172/JCI105486
  11. Ramsey WH, Wu GY. Hepatocellular carcinoma: update on diagnosis and treatment. Dig Dis 1995;13:81-91. https://doi.org/10.1159/000171490
  12. Gitlin D, Perricelli A, Gitlin GM. Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 1972;32:979-982.
  13. Taguchi J, Yano H, Sueda J, Yamaguchi R, Kojiro M, Shirouzu G, et al. Alpha-Fetoprotein-producing rectal carcinoma--a case report. Kurume Med J 1997;44:339-348. https://doi.org/10.2739/kurumemedj.44.339
  14. Sugaya Y, Sugaya H, Kuronuma Y, Hisauchi T, Harada T. A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). Gastroenterol Jpn 1989;24:325-331.
  15. Hiroshima K, Iyoda A, Toyozaki T, Haga Y, Baba M, Fujisawa T, et al. Alpha-fetoprotein-producing lung carcinoma: report of three cases. Pathol Int 2002;52:46-53. https://doi.org/10.1046/j.1440-1827.2002.01311.x
  16. Takayama H. A case of bladder cancer producing alphafetoprotein (AFP). Hinyokika Kiyo 1995;41:387-389.
  17. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-2222. https://doi.org/10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M
  18. Kim TB, Yu WS. Prognostic value of preoperative serum alpha-fetoprotein level in resectable gastric cancer. J Korean Gastric Cancer Assoc 2003;3:33-37.
  19. Joo YH, Jung HY, Kang GH, Youn HJ, Kim SY, Yang SK, et al. Clinico-pathological characteristics of the alpha-fetoprotein producing gastric carcinoma. Korean J Gastroenterol 2000;36:54-60.
  20. Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990;85:1480-1485.
  21. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002;19:359-365. https://doi.org/10.1159/000065838
  22. Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long Z, et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol 2010;102:249-255. https://doi.org/10.1002/jso.21624
  23. McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975;35:991-996.
  24. Kumashiro Y, Yao T, Aishima S, Hirahashi M, Nishiyama K, Yamada T, et al. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol 2007;38:857-863. https://doi.org/10.1016/j.humpath.2006.10.020
  25. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996;3:393-404.
  26. Sato Y, Nishimaki T, Date K, Shirai Y, Kurosaki I, Saito Y, et al. Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case. Surg Today 1999;29:1075-1078. https://doi.org/10.1007/s005950050647
  27. Tsurumachi T, Yamamoto H, Watanabe K, Honda I, Watanabe S, Yamada S, et al. Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case. Surg Today 1997;27:563-566. https://doi.org/10.1007/BF02385813

Cited by

  1. Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report vol.13, pp.1, 2011, https://doi.org/10.5230/jgc.2013.13.1.58
  2. Clinicopathological Characteristics and Prognosis of Alpha-fetoprotein Producing Gastric Cancer vol.62, pp.6, 2011, https://doi.org/10.4166/kjg.2013.62.6.327
  3. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association vol.17, pp.1, 2014, https://doi.org/10.1007/s10120-013-0259-5
  4. Endometrial hepatoid adenocarcinoma: A rare cause of elevated serum α‐fetoprotein vol.40, pp.3, 2011, https://doi.org/10.1111/jog.12237
  5. Expression of CD24, p21, p53, and c‐myc in alpha‐fetoprotein‐producing gastric cancer: Correlation with clinicopathologic characteristics and survival vol.109, pp.8, 2011, https://doi.org/10.1002/jso.23599
  6. Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases vol.10, pp.5, 2015, https://doi.org/10.3892/ol.2015.3731
  7. High level of Serum AFP is an Independent Negative Prognostic Factor in Gastric Cancer vol.30, pp.4, 2015, https://doi.org/10.5301/jbm.5000167
  8. Alpha-fetoprotein (AFP) Elevation Gastric Adenocarcinoma and Importance of AFP Change in Tumor Response Evaluation vol.16, pp.5, 2011, https://doi.org/10.7314/apjcp.2015.16.5.2003
  9. Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy vol.5, pp.None, 2011, https://doi.org/10.1038/srep17516
  10. Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma vol.7, pp.19, 2011, https://doi.org/10.18632/oncotarget.8571
  11. α-fetoprotein-producing gastric carcinoma: A case report of a rare subtype and literature review vol.11, pp.5, 2016, https://doi.org/10.3892/ol.2016.4372
  12. A Case of Alpha-Fetoprotein (AFP)-producing Gastric Cancer with Long-term Survival vol.77, pp.2, 2011, https://doi.org/10.3919/jjsa.77.346
  13. Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer vol.14, pp.1, 2017, https://doi.org/10.3892/ol.2017.6240
  14. Influence of high serum alpha fetoprotein on patients with gastric cancer vol.4, pp.2, 2017, https://doi.org/10.1002/aid2.12050
  15. Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma vol.7, pp.2, 2017, https://doi.org/10.3892/mco.2017.1288
  16. miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer vol.10, pp.10, 2011, https://doi.org/10.4251/wjgo.v10.i10.344
  17. The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells vol.52, pp.1, 2011, https://doi.org/10.1267/ahc.18044
  18. Development of an Immunoradiometric Assay (IRMA) for Binding of an 125I-anti AFP Antibody to Alpha Fetoprotein (AFP) In Gastric Adenocarcinoma And Gastric Lymphoma Tissues vol.28, pp.1, 2011, https://doi.org/10.4993/acrt.28.35
  19. Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis vol.48, pp.3, 2011, https://doi.org/10.1177/0300060519899780
  20. Rapidly progressed large cell neuroendocrine carcinoma of the stomach with an increased serum alpha fetoprotein level: a case report vol.13, pp.2, 2011, https://doi.org/10.1007/s12328-019-01041-2